Nuzenio

Marketbeat Protagonist Therapeutics

Marketbeat Protagonist Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 20 latest news signals 1 publisher sources 100/100 entity strength

Latest news

HC Wainwright Has Negative Forecast for PTGX FY2026 Earnings - MarketBeatMarketBeat · Mon, 10 Aug 2026 05:29:16 GMT Protagonist Therapeutics (NASDAQ:PTGX) Rating Lowered to Buy at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:55:54 GMT HC Wainwright Has Negative Forecast for PTGX Q3 Earnings - MarketBeatMarketBeat · Fri, 07 Aug 2026 10:23:12 GMT Bank of America Corp DE Has $136.54 Million Stock Position in Protagonist Therapeutics, Inc. $PTGX - MarketBeatMarketBeat · Fri, 07 Aug 2026 07:31:39 GMT Citigroup Forecasts Strong Price Appreciation for Protagonist Therapeutics (NASDAQ:PTGX) Stock - MarketBeatMarketBeat · Thu, 06 Aug 2026 20:16:33 GMT Protagonist Therapeutics (NASDAQ:PTGX) Hits New 12-Month High Following Strong Earnings - MarketBeatMarketBeat · Thu, 06 Aug 2026 14:50:37 GMT Protagonist Therapeutics, Inc. $PTGX Shares Acquired by California State Teachers Retirement System - MarketBeatMarketBeat · Thu, 06 Aug 2026 08:06:02 GMT Protagonist Therapeutics (NASDAQ:PTGX) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeatMarketBeat · Thu, 06 Aug 2026 04:01:06 GMT

Timeline

Mon, 10 Aug 2026 05:29:16 GMTHC Wainwright Has Negative Forecast for PTGX FY2026 Earnings - MarketBeat

Sat, 08 Aug 2026 07:55:54 GMTProtagonist Therapeutics (NASDAQ:PTGX) Rating Lowered to Buy at Wall Street Zen - MarketBeat

Fri, 07 Aug 2026 10:23:12 GMTHC Wainwright Has Negative Forecast for PTGX Q3 Earnings - MarketBeat

Fri, 07 Aug 2026 07:31:39 GMTBank of America Corp DE Has $136.54 Million Stock Position in Protagonist Therapeutics, Inc. $PTGX - MarketBeat

Thu, 06 Aug 2026 20:16:33 GMTCitigroup Forecasts Strong Price Appreciation for Protagonist Therapeutics (NASDAQ:PTGX) Stock - MarketBeat

Thu, 06 Aug 2026 14:50:37 GMTProtagonist Therapeutics (NASDAQ:PTGX) Hits New 12-Month High Following Strong Earnings - MarketBeat

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Protagonist Therapeutics29 live mentions Inc26 live mentions PTGX24 live mentions Shares12 live mentions PTGX MarketBeat MarketBeat10 live mentions NASDAQ8 live mentions PTGX Shares Acquired4 live mentions MarketBeat3 live mentions HC Wainwright Has2 live mentions Negative Forecast2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Protagonist Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.